关于本ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS).
来自基金数据提供商的描述 · 截至以下日期的概况: Oct 10, 2026.
价格走势图
每日收盘价(价格回报,非总回报)。对比折线图以区间起始点为基准,标准化为百分比变动。 来源: Financial Modeling Prep.
业绩表现
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | 成立* | |
|---|---|---|---|---|---|---|---|---|---|
| 价格回报 | — | — | — | — | — | -52.53% | -33.31% | -15.70% | -2.85% |
| 总回报 | — | — | — | — | — | -52.46% | -33.24% | -15.51% | -2.67% |
* 已年化。总回报率采用股息调整后价格序列计算(分红再投入);价格回报率采用未经调整的收盘价计算。 业绩截至 Jul 10, 2025. 过往业绩不代表未来表现。
费率
| 净费率 | 0.40% | 每10,000美元投资的年化费用 | $40.00 |
仅供示意的费用测算:费用率 × $10,000。不含交易成本、买卖价差、税费及投资价值变动。总费用率与净费用率的详情及任何费用减免安排,请参阅招募说明书。
持仓明细
持仓数据截至 Oct 10, 2026 · 数据提供商报告的投资组合日期;持仓数据非实时仓位。 65 数据库总行数.
| # | 持仓 | 代码 | 权重 | 股票 | 市值 |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 2.67% | 105.59K | $23.8M |
| 2 | Illumina Inc | ILMN | 2.18% | 69.86K | $19.4M |
| 3 | Revvity Inc | PKI | 2.00% | 115.59K | $17.8M |
| 4 | Mettler-Toledo International Inc | MTD | 1.93% | 11.10K | $17.2M |
| 5 | Intuitive Surgical Inc | ISRG | 1.93% | 40.53K | $17.2M |
| 6 | Agilent Technologies Inc | A | 1.90% | 98.93K | $16.9M |
| 7 | Veeva Systems Inc | VEEV | 1.83% | 54.93K | $16.3M |
| 8 | AbbVie Inc | ABBV | 1.77% | 57.07K | $15.8M |
| 9 | Thermo Fisher Scientific Inc | TMO | 1.75% | 23.64K | $15.6M |
| 10 | West Pharmaceutical Services Inc | WST | 1.75% | 42.50K | $15.6M |
| 11 | Charles River Laboratories International Inc | CRL | 1.74% | 51.40K | $15.5M |
| 12 | Humana Inc | HUM | 1.73% | 35.76K | $15.4M |
| 13 | Danaher Corp | DHR | 1.73% | 69.93K | $15.4M |
| 14 | Waters Corp | WAT | 1.72% | 35.38K | $15.3M |
| 15 | Biogen Inc | BIIB | 1.72% | 67.90K | $15.3M |
| 16 | Viatris Inc | VTRS | 1.72% | 867.97K | $15.3M |
| 17 | HCA Healthcare Inc | HCA | 1.72% | 33.90K | $15.3M |
| 18 | Amgen Inc | AMGN | 1.70% | 36.59K | $15.2M |
| 19 | McKesson Corp | MCK | 1.69% | 16.05K | $15.1M |
| 20 | Eli Lilly & Co | LLY | 1.68% | 12.71K | $15.0M |
| 21 | ResMed Inc | RMD | 1.68% | 65.13K | $15.0M |
| 22 | Elevance Health Inc | ANTM | 1.67% | 36.03K | $14.9M |
| 23 | Gilead Sciences Inc | GILD | 1.67% | 98.27K | $14.9M |
| 24 | Becton Dickinson & Co | BDXA | 1.64% | 79.66K | $14.6M |
| 25 | Centene Corp | CNC | 1.64% | 223.55K | $14.6M |
点击股票代码,查看所有持有该证券的ETF。
行业敞口
地区敞口
国家/地区权重以数据提供商报告为准。发达/新兴/前沿市场的分类标签遵循方法论页面中的分类标准。 货币对冲: 基金名称中未显示对冲信息.
分红记录
| 收益率(TTM) | 0.06% | 已派发(过去12个月) | $0.1718 |
| 频率 | Quarterly | SEC收益率 | 我们的数据来源未提供此项,请参阅发行商页面 |
| 最近除息日 | Jun 22, 2026 | 最近派息 | $0.0627 |
| 1年增长率 | -24.41% | 3年/5年增长率(年化) | -3.82% / +4.80% |
| 除息日 | 股权登记日 | 派息日 | 金额 |
|---|---|---|---|
| Jun 22, 2026 | — | — | $0.0627 |
| Mar 23, 2026 | — | — | $0.0561 |
| Dec 22, 2025 | — | — | $0.0530 |
| Sep 22, 2025 | — | — | $0.0599 |
| Jun 23, 2025 | — | — | $0.0555 |
| Mar 24, 2025 | — | — | $0.0551 |
| Dec 23, 2024 | — | — | $0.0569 |
| Sep 23, 2024 | — | — | $0.0547 |
| Jun 24, 2024 | — | — | $0.0508 |
| Mar 18, 2024 | — | — | $0.0459 |
| Dec 18, 2023 | — | — | $0.0499 |
| Sep 18, 2023 | — | — | $0.0479 |
追踪分派收益率 = 过去 12 个月现金分派 ÷ 当前价格。此数据并非 SEC 30 日收益率,且分派金额不保证持续。 差异解析 →
风险统计
流动性
| 今日成交量 | 8.41K | 平均成交量 | 8.12K |
| AUM | $960.7M | 溢价/折价 | +885.11% |
| 买卖价差 | 我们的数据来源未提供此信息。请查看您券商的报价页面;买卖价差在开盘和收盘时最大。 | ||
溢价/折价将延迟市场价格与最新报告NAV进行对比,为参考性数据,非官方收盘溢价/折价。 ETF流动性机制详解 →
基金官方资源
外部链接将在新标签页中打开发行商官网或SEC EDGAR。招募说明书及官方文件始终是权威依据,投资前请务必仔细阅读。
最新资讯: RYH
过去7天内暂无文章直接提及该基金,现显示ETF综合资讯。
使用指引:AUM为基金规模;费用率为内嵌于收益中的年度成本;NAV为基金每份资产净值,市场价格可能略高于NAV(溢价)或略低于NAV(折价);总回报假设分配收益已再投资。每项数据集均显示各自的截止日期,因为持仓、资产和报价的更新频率不同。
RYH